148 related articles for article (PubMed ID: 2836665)
1. Immunophenotype of leukemic blasts with small peroxidase-positive granules detected by electron microscopy.
Vainchenker W; Villeval JL; Tabilio A; Matamis H; Karianakis G; Guichard J; Henri A; Vernant JP; Rochant H; Breton-Gorius J
Leukemia; 1988 May; 2(5):274-81. PubMed ID: 2836665
[TBL] [Abstract][Full Text] [Related]
2. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia, FAB M-1 microgranular variant: a multiparameter study.
Nguyen D; Brynes RK; Macaulay L; Kaplan B; Pinter-Brown LC
Hematol Pathol; 1989; 3(1):11-22. PubMed ID: 2545666
[TBL] [Abstract][Full Text] [Related]
4. Comparison of myeloperoxidase detection by flow cytometry using two different clones of monoclonal antibodies.
Leong CF; Kalaichelvi AV; Cheong SK; Hamidah NH; Rahman J; Sivagengei K
Malays J Pathol; 2004 Dec; 26(2):111-6. PubMed ID: 16329563
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic, genotypic, cytochemical, and ultrastructural characterization of acute undifferentiated leukemia.
Campana D; Hansen-Hagge TE; Matutes E; Coustan-Smith E; Yokota S; Shetty V; Bartram CR; Janossy G
Leukemia; 1990 Sep; 4(9):620-4. PubMed ID: 2395382
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
[TBL] [Abstract][Full Text] [Related]
7. [Cytomorphology of acute mixed leukemia].
Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
[TBL] [Abstract][Full Text] [Related]
9. "Pan-myeloid" reagent: the monoclonal antibody MCS-2 in the routine immunodiagnostic service of leukemia phenotyping.
Drexler HG; Sagawa K; Menon M; Minowada J
Jpn J Cancer Res; 1985 Mar; 76(3):235-9. PubMed ID: 3922842
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody study of Philadelphia chromosome-positive blastic leukemias using the alkaline phosphatase anti-alkaline phosphatase (APAAP) technic.
Neumann MP; de Solas I; Parkin JL; Gajl-Peczalska K; McKenna RW; Berkley CK; Nichols WL; Brunning RD
Am J Clin Pathol; 1986 May; 85(5):564-72. PubMed ID: 3518397
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis.
Tien HF; Wang CH; Chuang SM; Lee FY; Liu MC; Chen YC; Shen MC; Lin DT; Lin KH; Lin KS
Leukemia; 1992 Sep; 6(9):907-14. PubMed ID: 1325582
[TBL] [Abstract][Full Text] [Related]
12. Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques.
Stasi R; Del Poeta G; Venditti A; Bruno A; Suppo G; Aronica G; Di Carlo G; Papa G
Hematol Pathol; 1995; 9(2):79-94. PubMed ID: 7559258
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity in acute undifferentiated leukemia.
LeMaistre A; Childs CC; Hirsch-Ginsberg C; Reuben J; Cork A; Trujillo JM; Andersson B; McCredie KB; Freireich E; Stass SA
Hematol Pathol; 1988; 2(2):79-90. PubMed ID: 3198552
[TBL] [Abstract][Full Text] [Related]
14. Relevance of ultrastructural immunocytochemistry in the characterization of unclassifiable leukemias: correlation with phenotypic and genic studies.
Polli N; Lambertenghi-Deliliers G; Schirò R; Cattoretti G; Soligo D; Cantù-Rajnoldi A; Romitti L; Delia D; Polli EE
Haematologica; 1989; 74(2):129-36. PubMed ID: 2545574
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural and cytochemical characterization of blasts from early erythroblastic leukemias.
Breton-Gorius J; Villeval JL; Mitjavila MT; Vinci G; Guichard J; Rochant H; Flandrin G; Vainchenker W
Leukemia; 1987 Mar; 1(3):173-81. PubMed ID: 3118105
[TBL] [Abstract][Full Text] [Related]
16. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
Shumak KH; Baker MA; Taub RN; Coleman MS
Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
[TBL] [Abstract][Full Text] [Related]
17. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
18. Electron microscopic and cytochemical studies of peroxidase-negative acute nonlymphoblastic leukemia.
Eguchi M; Mikami T; Kurosawa H; Sugita K; Furukawa T; Tsunoda S; Miura Y
Med Electron Microsc; 2001 Mar; 34(1):61-70. PubMed ID: 11479774
[TBL] [Abstract][Full Text] [Related]
19. Use of myeloperoxidase mRNA as a marker for myeloid lineage in acute leukemias.
Crisan D; David D; DiCarlo R
Arch Pathol Lab Med; 1996 Sep; 120(9):828-34. PubMed ID: 9140287
[TBL] [Abstract][Full Text] [Related]
20. Myeloid surface antigen-positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics.
Childs CC; Hirsch-Ginsberg C; Walters RS; Andersson BS; Reuben J; Trujillo JM; Cork A; Stass SA; Freireich EJ; Zipf TF
Leukemia; 1989 Nov; 3(11):777-83. PubMed ID: 2811478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
